The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| INDV | +204.37% | +283.04% | +30.75% | +217% |
| S&P | +11% | +85.61% | +13.15% | +216% |
Indivior PLC is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $314.00M | 2.3% |
| Gross Profit | $252.00M | 5.9% |
| Gross Margin | 80.25% | 2.7% |
| Market Cap | $3.01B | 136.6% |
| Market Cap / Employee | $2.86M | 0.0% |
| Employees | 1.1K | -9.7% |
| Net Income | $42.00M | 950.0% |
| EBITDA | $104.00M | 41.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $445.00M | 54.5% |
| Accounts Receivable | $259.00M | 3.2% |
| Inventory | 155 | -12.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $328.00M | 21.5% |
| Short Term Debt | $28.00M | 100.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 8.82% | 8.9% |
| Return On Invested Capital | -75.35% | -77.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$62.40M | -4050.0% |
| Operating Free Cash Flow | -$41.96M | -575.0% |
| Metric | Q4 2023 | Q1 2024 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 872.57 | 516.14 | 20.80 | 24.00 | - |
| Price to Book | -9.64 | -3.42 | -6.46 | -11.73 | 55.01% |
| Price to Sales | 1.31 | 1.02 | 1.58 | 2.64 | 139.46% |
| Price to Tangible Book Value | -4.51 | -3.37 | -6.31 | -11.42 | 222.59% |
| Price to Free Cash Flow TTM | 221.31 | 8.89 | 9.36 | 23.13 | - |
| Enterprise Value to EBITDA | 16.14 | 16.28 | 23.15 | 29.05 | 68.42% |
| Free Cash Flow Yield | 0.5% | 11.3% | 10.7% | 4.3% | - |
| Return on Equity | 7.8% | 12.2% | - | ||
| Total Debt | $375.00M | $370.00M | $366.00M | $356.00M | 25.35% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
